Atlas Trials

Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers

Clinical trial NCT05202288 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05202288
Sponsor
ANRS, Emerging Infectious Diseases
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Ebola Virus Disease
Start date
2027-01-01
Primary completion
2027-08-01
Enrollment
132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.